Product Information
AMLODIPINE-BENAZEPRIL 2.5-10 is a generic product labeled by BluePoint Laboratories, priced at $0.0956 per EA under NDC 68001013200. Its NADAC has been published 652 times since Apr 9, 2014.
FDA first approved this application on Feb 5, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5; 10 mg/1; mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001013200
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078466FDA Approved
2/5/2010
TE Code
AB
On Market Since
7/16/2015
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has been published 652 times since Apr 9, 2014, and over the history we have for it it has declined 81.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0956 per EA |
|---|---|
| All-time high | $0.6878 (May 14, 2014) |
| All-time low | $0.0735 (Apr 17, 2024) |
| 52-week high | $0.1061 |
| 52-week low | $0.0930 |
| Median price | $0.1503 |
| Average price | $0.2443 |
| Largest weekly change | +58.1% (Sep 19, 2018) |
| Weeks tracked | 652 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine Besylate and Benazepril Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-BENAZEPRIL 2.5-10?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 2.5-10, manufactured by BluePoint Laboratories, is $0.0956 per EA (NDC 68001013200), effective Sep 30, 2026.
How has the price of AMLODIPINE-BENAZEPRIL 2.5-10 changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has declined 81.1%. It has been tracked across 652 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 2.5-10?
Since Apr 9, 2014, the NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has ranged from a low of $0.0735 (Apr 17, 2024) to a high of $0.6878 (May 14, 2014), with a median of $0.1503 per EA.
Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 2.5-10?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-BENAZEPRIL 2.5-10 in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-BENAZEPRIL 2.5-10?
AMLODIPINE-BENAZEPRIL 2.5-10 (NDC 68001013200) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.